<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-21T23:46:16+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>下一代罕见病基因疗法，砥砺前行</title>
    <updated>2021-01-21T19:08:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/gmcD69_hIlFavUuvCpu6gw</id>
    <link href="https://mp.weixin.qq.com/s/gmcD69_hIlFavUuvCpu6gw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>收购浪潮冲击下，ADC癌症治疗火热</title>
    <updated>2021-01-20T19:49:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/8okugltD-ZgZdA_u4P9TyA</id>
    <link href="https://mp.weixin.qq.com/s/8okugltD-ZgZdA_u4P9TyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不是CAR-T/NK/M，新型细胞治疗技术来了，目标是攻克实体瘤！</title>
    <updated>2021-01-19T13:26:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/mek9J9u3z_dkq3xs20nJbA</id>
    <link href="https://mp.weixin.qq.com/s/mek9J9u3z_dkq3xs20nJbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>小分子RNA靶向疗法热潮渐起，全球制药巨头纷涌而至</title>
    <updated>2021-01-18T21:03:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/nuRhH5lBZR892z98wpT3oQ</id>
    <link href="https://mp.weixin.qq.com/s/nuRhH5lBZR892z98wpT3oQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲押注KLRG1抗体！这家免疫疗法公司完成4200万美元A1轮融资，主攻癌症和自身免疫性疾病</title>
    <updated>2021-01-17T20:59:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/TMhgFxtbL_L0IQe3eiSdUg</id>
    <link href="https://mp.weixin.qq.com/s/TMhgFxtbL_L0IQe3eiSdUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CRISPR治疗痤疮！卢冠达联合创办的Eligo与GSK达成最新合作，交易总额2.24亿美元</title>
    <updated>2021-01-16T21:01:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/cgRmLJIdLmPM-e2jzSQebw</id>
    <link href="https://mp.weixin.qq.com/s/cgRmLJIdLmPM-e2jzSQebw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲斥资超10亿美元，拿下ILT2抗体！这款新型癌症免疫疗法究竟有何优势？</title>
    <updated>2021-01-15T21:11:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/A7ksYw-dJIzoWeutQy1q8A</id>
    <link href="https://mp.weixin.qq.com/s/A7ksYw-dJIzoWeutQy1q8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>主攻RNAi疗法！诺奖得主创立的Atalanta以1.1亿美元启动，与Biogen、罗氏已达成合作</title>
    <updated>2021-01-14T21:00:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/GN96L8Tos0cIRhjWTJBE9A</id>
    <link href="https://mp.weixin.qq.com/s/GN96L8Tos0cIRhjWTJBE9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“神刊”CA最新癌症统计：美国癌症死亡率连续第二年破纪录下降</title>
    <updated>2021-01-13T20:58:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/KEeMP4pNpFbrBBroUhKoew</id>
    <link href="https://mp.weixin.qq.com/s/KEeMP4pNpFbrBBroUhKoew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>常兴点评 | Nature里程碑：碱基编辑疗法获突破！治疗早衰症，小鼠寿命从7个月延长至1.5年</title>
    <updated>2021-01-12T20:59:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/T4FxxuaiIIV_D_kdJWyusw</id>
    <link href="https://mp.weixin.qq.com/s/T4FxxuaiIIV_D_kdJWyusw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>